top of page

Team
Technology
Investors
Join Us
News
Contact
Privacy Policy
Terms & Conditions
Candidate Privacy Notice
More

Use tab to navigate through the menu items.

News

Theolytics is taking part in the BIA Research Relay 2021

Theolytics is taking part in the BIA Research Relay 2021

Theolytics is taking part in the BIA Research Relay 2021

We’re delighted to announce that we’re all taking part in the BioIndustry Association’s Research Relay 2021 to raise money for Ovarian...

Jul 1, 2021

Theolytics announces appointment of Immatics’ Carsten Reinhardt to its Board of Directors

Theolytics announces appointment of Immatics’ Carsten Reinhardt to its Board of Directors

Theolytics announces appointment of Immatics’ Carsten Reinhardt to its Board of Directors

Theolytics, today announced the Board appointment of Carsten Reinhardt MD PhD. Oxford, UK, 21st September 2020 Theolytics, a biotech...

Sep 21, 2020

Theolytics raises $6.8 million Series A round co-led by Epidarex Capital and Taiho Ventures

Theolytics raises $6.8 million Series A round co-led by Epidarex Capital and Taiho Ventures

Theolytics raises $6.8 million Series A round co-led by Epidarex Capital and Taiho Ventures

Theolytics raises $6.8 million Series A round co-led by Epidarex Capital and Taiho Ventures to advance viral cancer therapies. Oxford,...

Jan 7, 2020

The Sherard Building, Edmund Halley Road, Oxford Science Park
Oxford, OX4 4DQ, England

© 2021 Theolytics®. All rights reserved.

Privacy Policy | Terms and Conditions | Careers

bottom of page